Literature DB >> 25494359

Time required for institutional review board review at one Veterans Affairs medical center.

Daniel E Hall1, Barbara H Hanusa2, Roslyn A Stone3, Bruce S Ling4, Robert M Arnold5.   

Abstract

IMPORTANCE: Despite growing concern that institutional review boards (IRBs) impose burdensome delays on research, little is known about the time required for IRB review across different types of research.
OBJECTIVE: To measure the overall and incremental process times for IRB review as a process of quality improvement. DESIGN, SETTING, AND PARTICIPANTS: After developing a detailed process flowchart of the IRB review process, 2 analysts abstracted temporal data from the records pertaining to all 103 protocols newly submitted to the IRB at a large urban Veterans Affairs medical center from June 1, 2009, through May 31, 2011. Disagreements were reviewed with the principal investigator to reach consensus. We then compared the review times across review types using analysis of variance and post hoc Scheffé tests after achieving normally distributed data through logarithmic transformation. MAIN OUTCOMES AND MEASURES: Calendar days from initial submission to final approval of research protocols.
RESULTS: Initial IRB review took 2 to 4 months, with expedited and exempt reviews requiring less time (median [range], 85 [23-631] and 82 [16-437] days, respectively) than full board reviews (median [range], 131 [64-296] days; P = .008). The median time required for credentialing of investigators was 1 day (range, 0-74 days), and review by the research and development committee took a median of 15 days (range, 0-184 days). There were no significant differences in credentialing or research and development times across review types (exempt, expedited, or full board). Of the extreme delays in IRB review, 80.0% were due to investigators' slow responses to requested changes. There were no systematic delays attributable to the information security officer, privacy officer, or IRB chair. CONCLUSIONS AND RELEVANCE: Measuring and analyzing review times is a critical first step in establishing a culture and process of continuous quality improvement among IRBs that govern research programs. The review times observed at this IRB are substantially longer than the 60-day target recommended by expert panels. The method described here could be applied to other IRBs to begin identifying and improving inefficiencies.

Entities:  

Mesh:

Year:  2015        PMID: 25494359      PMCID: PMC4527305          DOI: 10.1001/jamasurg.2014.956

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  14 in total

1.  Variability in the costs of institutional review board oversight.

Authors:  Margaret M Byrne; Jeanne Speckman; Ken Getz; Jeremy Sugarman
Journal:  Acad Med       Date:  2006-08       Impact factor: 6.893

2.  Barriers to clinical trials vary according to the type of trial and the institution.

Authors:  Rangaswamy Govindarajan; James W Young; Cherie L Harless; Laura F Hutchins
Journal:  J Clin Oncol       Date:  2007-04-20       Impact factor: 44.544

3.  Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions.

Authors:  Liselotte N Dyrbye; Matthew R Thomas; Alex J Mechaber; Anne Eacker; William Harper; F Stanford Massie; David V Power; Tait D Shanafelt
Journal:  Acad Med       Date:  2007-07       Impact factor: 6.893

4.  Impact of recent legislative bills regarding clinical research on Italian ethics committee activity.

Authors:  L Porcu; D Poli; V Torri; E Rulli; M C Di Tullio; M Cinquini; E Bajetta; R Labianca; F Di Costanzo; D Nitti; I Floriani
Journal:  J Med Ethics       Date:  2008-10       Impact factor: 2.903

5.  Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugs.

Authors:  S M Belknap; C H Georgopoulos; D P West; P R Yarnold; W N Kelly
Journal:  Clin Pharmacol Ther       Date:  2010-06-23       Impact factor: 6.875

6.  Variations among Institutional Review Board reviews in a multisite health services research study.

Authors:  Kathleen Dziak; Roger Anderson; Mary Ann Sevick; Carol S Weisman; Douglas W Levine; Sarah Hudson Scholle
Journal:  Health Serv Res       Date:  2005-02       Impact factor: 3.402

7.  Changes in the institutional review board submission process for multicenter research over 6 years.

Authors:  Monika Pogorzelska; Patricia W Stone; Elizabeth Gross Cohn; Elaine Larson
Journal:  Nurs Outlook       Date:  2010 Jul-Aug       Impact factor: 3.250

8.  Ethical dilemmas of a large national multi-centre study in Australia: time for some consistency.

Authors:  Andrea Driscoll; Judy Currey; Linda Worrall-Carter; Simon Stewart
Journal:  J Clin Nurs       Date:  2008-08       Impact factor: 3.036

9.  Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.

Authors:  David A Dorr; Rachel Burdon; Dennis P West; Jennifer Lagman; Christina Georgopoulos; Steven M Belknap; June M McKoy; Benjamin Djulbegovic; Beatrice J Edwards; Sigmund A Weitzman; Simone Boyle; Martin S Tallman; Moshe Talpaz; Oliver Sartor; Charles L Bennett
Journal:  Clin Cancer Res       Date:  2009-05-19       Impact factor: 12.531

10.  Costs and benefits of the national cancer institute central institutional review board.

Authors:  Todd H Wagner; Christine Murray; Jacquelyn Goldberg; Jeanne M Adler; Jeffrey Abrams
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

View more
  6 in total

1.  A Rare Opportunity: Examining the Experience of a New Institutional Review Board.

Authors:  Linda Parreco; Lisa Rooney; Sharon Hampp; Amanda Brown; Lori Minasian
Journal:  J Empir Res Hum Res Ethics       Date:  2019-05-20       Impact factor: 1.742

2.  Evaluating IACUCs: Previous Research and Future Directions.

Authors:  Madeline L Budda; Stacy L Pritt
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-09-14       Impact factor: 1.232

3.  Effects of Regulatory Support Services on Institutional Review Board Turnaround Times.

Authors:  Pankaja Desai; Priyanka Nasa; Jackie Soo; Cunhui Jia; Michael L Berbaum; James H Fischer; Timothy P Johnson
Journal:  J Empir Res Hum Res Ethics       Date:  2017-04-16       Impact factor: 1.742

4.  Time required to review research protocols at 10 Veterans Affairs Institutional Review Boards.

Authors:  Patrick R Varley; Ulrike Feske; Shasha Gao; Roslyn A Stone; Sijian Zhang; Robert Monte; Robert M Arnold; Daniel E Hall
Journal:  J Surg Res       Date:  2016-06-08       Impact factor: 2.192

5.  A personalized Institutional Review Board Liaison Service: Evaluation over its initial 30 months.

Authors:  Zainab Abedin; Alan Teller; Brenda Ruotolo; Kawthar Muhammad; Deborah F Stiles; Rui Ferreira; Nancy Green
Journal:  Int J Acad Med       Date:  2020-06-29

6.  Time required to initiate outbreak and pandemic observational research.

Authors:  Asgar H Rishu; Nicole Marinoff; Lisa Julien; Mariana Dumitrascu; Nicole Marten; Shauna Eggertson; Su Willems; Stacy Ruddell; Dan Lane; Bruce Light; Henry T Stelfox; Philippe Jouvet; Richard Hall; Steven Reynolds; Nick Daneman; Robert A Fowler
Journal:  J Crit Care       Date:  2017-03-01       Impact factor: 3.425

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.